🇺🇸 FDA
Pipeline program

Prednisolone

RES106087

Phase 1 small_molecule completed

Quick answer

Prednisolone for Pulmonary Disease, Chronic Obstructive is a Phase 1 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).

Program details

Company
GlaxoSmithKline
Indication
Pulmonary Disease, Chronic Obstructive
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials